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Abstract Transcranial sonography (TCS) revealed reduced echogenicity of the brainstem
raphe (BR) as a characteristic ﬁnding in unipolar depression and in depression associated with
Parkinson’s or Wilson’s disease, but not in healthy adults, schizophrenia, multiple sclerosis
with depression or Parkinson’s disease without concomitant depression. Similar ﬁndings were
shown also for adjustment disorder with depressed mood. In contrast to unipolar depression,
sonographic ﬁndings of bipolar patients may generally indicate preserved structural integrity
of mesencephalic raphe structures. If bipolar disorder is associated with hypoechogenic BR,
depressive symptoms are more severe. BR hypoechogenicity could be caused by a modiﬁcation
of tissue cell density, the interstitial matrix composition or an alteration of ﬁber tracts integrity
representing involvement of the basal limbic system in the pathogenesis of unipolar depression
and depression associated with certain neurodegenerative diseases.
Recently it was shown that nigrostriatal dopaminergic system is abnormal in children with
attention-deﬁcit hyperactivity disorder which was expressed by signiﬁcantly larger echogenicity
of substantia nigra.
The increasingly broad application of TCS in the early and differential diagnosis of neu-
rodegenerative and psychiatric disorders in many centers all over the world is probably the
best evidence for the value of the method. Main advantages include the easy applicability,
the fact that it is quick and repeatedly performable with no limitations as known from other
neuroimaging techniques and that it is relatively cheap and side effect free.
© 2012 Elsevier GmbH.
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Open access under CC BY-NC-ND license.Transcranial sonography — historical overview
and method in psychiatric diseases
Transcranial sonography (TCS) is a relatively new neuroimag-
ing method which displays tissue echogenicity (intensity of
reﬂected ultrasound waves) of the brain through the intact
skull.
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Open access under CC BY-NC-ND license.Besides the speciﬁc ﬁnding of the substantia nigra (SN)
yperechogenicity in Parkinson’s disease (PD), ﬁrst time
escribed in 1995 by Becker et al. [1], a series of studies
sing TCS has reported another speciﬁc ultrasound feature:
tructural abnormality of the midbrain raphe depicted as
educed echogenicity or invisible brainstem raphe (BR) in
atients with unipolar depression compared with healthy
ndividuals [2,3]. The structural abnormality which was
eported to occur in unipolar depressed patients, was unre-
ated to severity of current illness, and was absent in
atients with schizophrenia [3]. The same structural abnor-
ality has also been reported when depressed patients have
een compared to non-depressed patients, having a variety
f neurological diseases, for example, PD [4,5], dystonic
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Figure 1 Sonographic images of corresponding midbrain axial
sections in three subjects. The butterﬂy-shaped hypoechognic
midbrain was encircled for better visualization (full line). Thick
arrows indicate brainstem raphe; red nucleus is encircled with
dotted line. (A) Mesencephalic brainstem of a healthy individual
with normal, highly echogenic brainstem raphe as a continuous
line which has the same echogenicity as the red nucleus. (B)
Mesencephalic brainstem of a patient with unipolar depression
with interrupted, reduced echogenicity of the brainstem raphe.
(C) Mesencephalic brainstem of a PD patient with depression
displays marked hyperechogenicity of the substantia nigra (thin
dotted arrow) and invisible brainstem raphe (thick full arrow).58
yndromes [6] and Wilson’s disease [7] but not multiple
clerosis with or without depression [8,9]. Modern clinical
CS systems display deep echogenic brain structures with a
igh image resolution of up to 0.7mm× 1mm which is even
igher than that of magnetic resonance imaging (MRI) under
linical conditions [10]. Meanwhile, consensus guidelines for
tandardized procedure of TCS of midbrain structures, basal
anglia and ventricles have been established [11,12], allow-
ng standardized scanning procedure and comparability of
CS ﬁndings between different research groups.
TCS of brain structures is performed through the tempo-
al acoustic bone window, with preauricular position of the
ltrasound probe parallel to the orbitomeatal line. Modern
linical ultrasound systems equipped with 2.0- to 3.5-MHz
ransducers can be applied [11,12]. The parameter settings
f the TCS system should be chosen as follows: dynamic
ange 45—60 dB, insonation depth 14—16 cm, time gain com-
ensation and image brightness are adapted as needed for
he best visualization. When the brain structure of interest
s clearly displayed, the image should be ﬁxed and zoomed
n two- to three-fold for further measurements [11]. The
xamination is performed at axial scanning planes through
he midbrain and the thalami [11,12]. The mesencephalic
rainstem can be depicted as a butterﬂy shaped structure
f low echogenicity surrounded by the highly echogenic
asal cisterns. The echogenicity of the ipsilateral SN, red
ucleus (RN) and the BR could be evaluated (Fig. 1). The
R is usually seen as a highly echogenic continuous line
ith an echogenicity that is identical to that of the RN
13]. Echogenicity of BR is rated semiquantitatively, using
ither a 3-point (grade 1: raphe invisible; grade 2: slightly
chogenic or interrupted BR; grade 3: high echogenicity
dentical to that of RN or basal cisterns) or, preferably, a 2-
oint (grade 0: invisible, hypoechogenic or interrupted BR;
rade 1: highly echogenic BR as a continuous line) grading
ystem [13]. It is important to scan the subject investigated
rom both sides, as the bone window may vary allowing
ufﬁcient visualization of the BR only if both sides are con-
idered. Therefore, if the BR can be depicted as continuous
ine from one side, it is rated as a normal (grade 1) — that
s, hyperechogenic, non-interrupted continuous line.
Changes in raphe echogenicity reﬂect changes in tissue
mpedance and point towards an alteration of the brainstem
icroarchitecture which could be due to a shift in tissue
ell density, a change in interstitial matrix composition, or
n alteration of ﬁber tract integrity [5,14]. Various anatom-
cal, physiological, and biochemical ﬁndings underline the
mportance of the basal limbic system in the pathogene-
is of affective disorders, and compelling evidence suggests
hat the nuclei, ﬁber tracts, and neurotransmitter sys-
ems associated with the basal limbic system are involved
n the pathogenesis of primary depression and depression
ssociated with some neurodegenerative diseases such as
D [15,16]. The change of acoustic impedance, which is
ecorded by TCS as reduced BR echogenicity, might be the
esult of microstructual changes, gliosis and disruption of
ber tract integrity [14].CS in unipolar depression
umerous evidence from neuroimaging, biochemical and
nimal studies implicates basal limbic system and raphe
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bTranscranial sonography in psychiatric diseases
nuclei involvement in the pathogenesis of the mood dis-
orders, particularly depression. Typical ultrasound marker
that can be of value in the diagnosis and differential diag-
nosis of depression is the low echogenicity or interrupted
BR. Raphe hypoechogenicity is a common ﬁnding in 50—70%
of patients with unipolar depression [2,17] and is asso-
ciated with responsivity to serotonin-reuptake inhibitors
(SSRI) [18]. In a pioneer study, echogenicity of the BR was
examined by TCS in 20 patients with unipolar depression
and 20 healthy adult controls. A marked reduction of raphe
echogenicity in depressed patients was found [2]. This ﬁnd-
ing was conﬁrmed a year later on larger number of patients
in the study which compared echogenicity of the BR between
40 patients with unipolar depression, 40 patients with bipo-
lar disorder and 40 healthy controls. Raphe echogenicity in
patients with unipolar depression was found to be distinctly
reduced as compared with healthy adults and patients with
bipolar affective disorder. BR echogenicity, on average, was
halved in the unipolar depressed group. No correlation was
found between BR echogenicity and age, sex or disease
severity [3]. Reduced brainstem midline echogenicity of
depressed patients was interpreted as a structural alter-
ation of the dorsal raphe nucleus or ﬁber tracts in this region
[14]. Increased T2-relaxation time in a pontine brainstem in
patients with major depression could be in line with previous
reports of brainstem pathology in these patients [14]. The
observation might indicate a subtle tissue alteration, which
cannot be identiﬁed by visual inspection of the images. T2-
relaxation time depends on physical tissue characteristics
and is inﬂuenced by hydration status or iron content. Differ-
ences in T2-relaxation time of speciﬁc brain areas between
patients with major depression and healthy controls may
indicate different tissue composition caused by histological
changes.
Several further studies conﬁrmed the ﬁnding of reduced
echogenicity of the BR in unipolar depression. In the study
of Walter [17] the frequency of patients with reduced
echogenicity of BR was higher in unipolar depression com-
pared with healthy individuals and in depressed PD patients
compared with non-depressed. The frequency of reduced
echogenicity of BR was the highest in patients with unipolar
depression. In this study, reduced echogenicity of the BR was
more frequent in depressed than in non-depressed patients,
irrespective of presence of PD.
TCS ﬁndings of another study [19], showed that reduced
echogenicity of pontomesencephalic BR is frequent in
depressive states, irrespective of diagnostic category of
depression, but only rare in healthy subjects without
any history of psychiatric disorder. BR echogenicity could
not discriminate between major depressive disorder and
adjustment disorder with depressed mood. BR echogenicity
scores showed in this study were signiﬁcantly lower in SSRI
responders compared with SSRI non-responders. Reduced BR
echogenicity indicated SSRI responsivity with a positive pre-
dictive value of 88%.
Recently, reduced raphe echogenicity was found in 47%
of the patients with major depressive disorder but only in
15% of healthy controls. In patients with suicidal ideations
that ﬁnding was even more pronounced (86%) with the high-
est frequency of completely not visible TCS raphe ﬁnding
(72%). Data showed that altered echogenicity of the BR is
frequent in patients with suicidal ideation. Normal raphe
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chogenicity in patients with major depression was associ-
ted with less severe depressive symptoms and rarely with
he presence of suicidal ideations [20].
Although there are several reports of MRI signal alteration
f BR in depression, a characteristic neuroimaging pattern
f BR abnormality has not yet been found [21].
Ultrasound investigations have been supplemented by
2-weighted MRI studies in order to investigate patho-
orphological pattern of the BR in depression. Increased
ntensity of the midline has been reported for unipolar
epressed patients when compared to bipolar patients and
ontrols in a retrospective study using T2-weighted MRI
22]. A difference between patients with major depres-
ion and control subjects for T2-relaxation times was found
n a region of interest located along the midline of the
ons. No difference was found between patients with bipolar
isorder and control subjects. Alterations of T2-relaxation
imes might indicate subtle tissue changes [23]. These ﬁnd-
ngs are in line with the results of pathoanatomic and PET
tudies demonstrating morphological and functional alter-
tion of the dorsal raphe nucleus in major depression,
ith decreased serotonin type 1A receptor binding and
ewer neurons expressing serotonin transporter mRNA com-
ared with ﬁndings in controls [24]. The relationship of BR
chogenicity and SSRI responsivity which was found in the
tudy of Walter [19] further supports the idea that reduced
R echogenicity reﬂects an alteration of the serotonergic
ystem.
In contrast with previous reports, no difference in
chogenicity of the BR of unipolar depressed patients was
ound in the study of Steele, the only one which investigated
ossible structural changes of the BR in unipolar depression
sing diffusion tensor imaging, did not conﬁrm structural
hanges of the BR in unipolar depressive patients using this
ethod [25]. One of the important advantages of TCS is that
t could also detect a subgroup of patients with depression
haracterized by mild clinical signs of parkinsonism who are
ossibly at an elevated risk of developing deﬁnite PD.
TCS data in a recent study showed that the ﬁnding of
N hyperechogenicity, which is characteristic for idiopathic
D, was related to motor asymmetry and reduced verbal
uency in patients with depressive disorders. This relation-
hip was even stronger in younger patients (<50 years) and
ndependent from age, in patients who had reduced BR
chogenicity [21]. Since, both liability for developing PD and
requency of PD-like TCS ﬁndings were found to be increased
n depression, patients with depressive disorders might be an
mportant population to screen for sonographic and clinical
igns of early PD.
CS in adjustment disorder with depressed
ood (ADDM)
ajor depressive disorder (MDD) and adjustment disorder
ith depressed mood (ADDM) are currently regarded as
istinct disease entities [26]. Especially, DSM axis-II comor-
idity and suicidal behavior have been reported to differ
etween MDD and ADDM. Following the Structured Clini-
al Interview for DSM-IV Axis-I Disorders [27], in the study
erformed by Walter et al. [18], 15 patients with single
pisode of MDD (MDDs), 22 with recurrent MDD (MDDr)
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nd 15 with ADDM. Reduced BR echogenicity was found
n 54% of the patients with MDD and ADDM, but only in
our (8%) of the healthy subjects. BR echogenicity scores
id not differ among patients with MDDs, MDDr, or ADDM,
nd pair-wise group comparisons failed to show differences
etween diagnostic groups with respect to frequency of
educed BR echogenicity. TCS ﬁndings of this study showed
hat reduced echogenicity of pontomesencephalic BR is
requent in depressive states, irrespective of diagnostic
ategory. As a result of the present study, the hypothesis
hat BR echogenicity might distinguish patients with MDD
nd patients with ADDM had to be rejected. Reduced BR
chogenicity is found with similar frequency in MDDs, MDDr,
nd ADDM. This is in agreement with results of clinical and
europhysiological studies suggesting common pathophysio-
ogical mechanisms in MDD and ADDM [28].
CS in bipolar disorder
ipolar affective disorders are characterized by recurrent
pisodes of depression as well as mania or hypomania [26].
n histological studies, subtle structural deﬁcits in the dor-
al raphe with a regional reduction in the synthesis of
oradrenalin have been described in patients with bipolar
isorder. The ﬁrst TCS study evaluated BR alterations in
atients with bipolar affective disorders, revealed normal
r even increased echogenicity of BR in bipolar disorder,
rrespective of the existing disease conditions. This obser-
ation led to the assumption that reduced echogenicity of
R may be speciﬁc to unipolar depression [3]. Recently, Kro-
ias et al. found the BR hypoechogenicity in 36.1% of the 36
atients with bipolar I disorder (14 depressed, 8 manic, 14
uthymic) and in 20% of the 35 healthy controls. Compared
o the control group, frequency of altered BR echogenici-
ies did not reach statistical signiﬁcance. Hypoechogenicity
f BR was depicted in six (42.9%) of the depressed, in three
37.5%) of the manic and in four (28.6%) of the euthymic
ipolar patients, with no signiﬁcant difference between the
hree subgroups [29].
The width of third ventricle was signiﬁcantly larger in the
atient group (3.8± 2.1mm vs. 2.7± 1.2mm). Depressed
ipolar patients with reduced BR echogenicity showed sig-
iﬁcantly higher scores on the Hamilton Depression Rating
cale as well as the Montgomery-Åsberg Depression Rating
cale [29].
Relating to echogenicity of SN, a strong trend of more
requent SN hyperechogenicities in the depressed subgroup
as identiﬁed. Hyperechogenic SN was seen in six patients
16.7%): ﬁve (35.7%) of the depressed, in none (0%) of the
anic and in one (7.1%) of the euthymic patients, indi-
ating cyclical dysregulation in quantitative dopaminergic
ransmission as one of the underlying pathologies in the
athogenesis of bipolar disorder.
One of the main conclusions to be drawn from the study
s that sonographic ﬁndings do not differ in different mood
tates of bipolar I disorder. Regarding the brainstem raphe,
ypoechogenicity is correlated to the severity of symptoms
n bipolar depression. Furthermore, bipolar patients in gen-
ral showed signiﬁcantly larger widths of the third ventricle
han the control group in this study [29].M.D. Mijajlovic
CS in attention-deﬁcit hyperactivity disorder
ttention-deﬁcit hyperactivity disorder (ADHD) is fre-
uent neuropsychiatric disorder characterized by excessive
otor activity, increased impulsivity and attention deﬁcits.
ypotheses about its pathophysiology implicate various neu-
otransmitters including dopamine [30]. One recent study
nvestigated echogenicity of the SN as a potential structural
arker for dysfunction of the nigrostriatal dopaminergic sys-
em in children with ADHD. Echogenicity of the SN in this
tudy was determined in 22 children with DSM-IV diagno-
is of ADHD and 22 healthy controls matched for age and
ex. The echogeniciity of SN was signiﬁcantly larger in ADHD
atients than in healthy controls (F1,42 = 9.298, p = 0.004,
ffect size = 0.92, speciﬁcity was 0.73 and sensitivity 0.82)
ithout effects of age or sex. The study showed that nigros-
riatal dopaminergic system is abnormal in children with
DHD. Increased SN echogenicity in ADHD patients relative
o healthy controls might be explained by a developmental
elay. Although most ﬁndings with regard to a presumptive
evelopmental delay in ADHD relate to diminished growth
f cortical thickness, recent studies have reported struc-
ural alterations in the basal ganglia of patients with ADHD.
t remains unclear whether an enlarged echogenic SN area
n ADHD patients can be attributed to a primary disturbance
f nigral iron metabolism, whether it is related to a pri-
ary developmental delay of brain structure, or whether it
ndicates a general structural marker for dysfunction of the
opaminergic system [31].
onclusion
he increasingly broad application of TCS in the early and
ifferential diagnosis of psychiatric and neurodegenerative
iseases in many centers all over the world is probably the
est evidence for the value of the method. The main advan-
ages include the easy applicability, even in moving (e.g.
remulous or agitated) patients, the fact that it is quick and
epeatedly performable with no limitations as known from
ther neuroimaging techniques (metal in the body as a lim-
tation for MRI imaging, speciﬁc medication as a limitation
or many forms of functional neuroimaging), and that it is
elatively cheap and side effect free.
It is a reliable method to investigate, diagnose
nd follow-up patients with unipolar depression, bipolar
isorder, ADHD and depression associated with some neu-
odegenerative diseases.
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